We also observed a significant acceleration of the clinical progression in exon 5–6 mutant TP53 gene CLL patients as compared with WTp53 CLL, whereas exon 7 mutants show a strong trend of faster clinical progression as compared with WTp53 CLL (Supplementary Figure 2 ).
← all excerpts
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O<sub>2-</sub>· production in cancer cells.
2
—
—
The sentences
We observed a significant acceleration of the clinical progression in frameshift mutant TP53 gene CLL patients as compared with WTp53 CLL, while missense mutants show a marked trend of faster clinical progression as compared with WTp53 CLL (Supplementary Figure 2 ).